Bimagrumab and sarcopenia
- PMID: 40471389
- PMCID: PMC12141158
- DOI: 10.1007/s40520-024-02915-3
Bimagrumab and sarcopenia
Conflict of interest statement
Declarations. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Bahat G, Ozkok S (2024) The current Landscape of Pharmacotherapies for Sarcopenia. Drugs Aging 41(2):83–112. 10.1007/s40266-023-01093-7 - PubMed
-
- Ozkok S, Aydin CO, Sacar DE, Catikkas NM, Erdogan T, Bozkurt ME, Kilic C, Karan MA, Bahat G (2022) Sarcopenic obesity versus sarcopenia alone with the use of probable Sarcopenia definition for Sarcopenia: associations with frailty and physical performance. Clin Nutr 41(11):2509–2516. 10.1016/j.clnu.2022.09.005 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
